首页> 外文期刊>Therapeutic Drug Monitoring >Interactions between drugs and Asian medicine: displacement of digitoxin from protein binding site by bufalin, the constituent of Chinese medicines Chan Su and Lu-Shen-Wan.
【24h】

Interactions between drugs and Asian medicine: displacement of digitoxin from protein binding site by bufalin, the constituent of Chinese medicines Chan Su and Lu-Shen-Wan.

机译:药物与亚洲药物之间的相互作用:蟾蜍灵从中枢神经系统中的蟾蜍灵取代了蛋白质结合位点。

获取原文
获取原文并翻译 | 示例
           

摘要

Asian medicines are widely used as alternative medicine. However, interactions between drugs and Asian medicines have been poorly studied. Chan Su and Lu-Shen-Wan are Asian medicines that contain the cardiaoactive compound bufalin. Bufalin is structurally similar to digitoxin and is also strongly bound to serum albumin. The authors studied possible displacement of digitoxin from the protein binding site by bufalin. The authors prepared three serum pools from patients taking digitoxin and supplemented aliquots of each serum pool with no bufalin (control) and 25 ng/mL, 50 ng/mL, 100 ng/mL, 250 ng/mL, 500 ng/mL, and 1000 ng/mL bufalin. The authors observed significant displacement of digitoxin by bufalin as evidenced by increased free digitoxin concentrations. For example, the concentration of free digitoxin increased from a control value of 1.6 ng/mL to 2.5 ng/mL in the presence of 1000 ng/mL bufalin (total digitoxin: 36.3 ng/mL) in the serum pool 1. The authors observed similar increases in free digitoxin concentrations in other serum pools in the presence of various concentrations of bufalin. The authors used a chemiluminescent assay and ACS:180 analyzer to measure both total (in the original serum) and free (in the protein-free ultrafiltrate) digitoxin concentrations because the chemiluminescent assay does not cross-react with bufalin. When an acetone/water (1:1 by volume) extract of Chan Su was added to a serum pool containing digitoxin, the authors observed a significantly increased free digitoxin concentration, indicating that Chan Su can displace digitoxin from the protein binding site in vitro. The authors conclude that bufalin and acetone/water extract of Chan Su can cause significant displacement of digitoxin from the protein binding site.
机译:亚洲药物被广泛用作替代药物。但是,药物与亚洲药物之间的相互作用研究很少。 Chan Su和Lu-Shen-Wan是含有心脏活性化合物bufalin的亚洲药物。蟾蜍灵在结构上类似于洋地黄毒蛋白,并且也与血清白蛋白牢固结合。作者研究了蟾蜍灵可能从蛋白结合位点置换洋地黄毒苷。作者从服用洋地黄毒的患者中制备了三个血清库,并补充了不含bufalin(对照)和25 ng / mL,50 ng / mL,100 ng / mL,250 ng / mL,500 ng / mL和1000 ng / mL布法林。作者观察到蟾蜍灵可显着置换洋地黄毒苷,这可通过增加游离洋地黄毒苷浓度来证明。例如,在血清池1中,在存在1000 ng / mL bufalin的情况下,游离洋地黄毒素的浓度从对照值1.6 ng / mL增加到2.5 ng / mL(总洋地黄毒苷:36.3 ng / mL)。在不同浓度的蟾蜍灵存在下,其他血清库中的游离洋地黄毒苷浓度也有类似的增加。作者使用化学发光测定法和ACS:180分析仪来测量总(原始血清中)和游离(无蛋白超滤液中)洋地黄毒素浓度,因为化学发光测定法不会与蟾蜍灵交叉反应。当将Chan Su的丙酮/水(体积比为1:1)提取物添加到含洋地黄毒素的血清池中时,作者观察到游离洋地黄毒素浓度显着增加,表明Chan Su可以在体外从蛋白质结合位点置换出洋地黄毒素。作者得出的结论是蟾蜍灵和蟾酥的丙酮/水提取物可导致洋地黄毒苷从蛋白质结合位点大量置换。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号